文献速递乳房整形与再造

光滑与毛面高填充圆形乳房假体初次隆胸后再手术率研究

Reoperation Rate After Primary Augmentation With Smooth, Textured, High Fill, Cohesive, Round Breast Implants (RANBI-I Study).
PubMed 文献 · Aesthet Surg J · 2019-01-01

该回顾性多中心研究评估了319例使用Natrelle Inspira假体(TruForm 1或2凝胶)行初次隆胸的女性,随访2-4年发现再手术率为9.4%,3年再手术风险率为9.9%,最常见原因为假体移位、包膜挛缩和患者要求更换假体尺寸或型号。

要点

  • 初次隆胸使用Inspira TruForm 2假体后再手术率低,与其它假体一致。
  • 再手术最常见原因为假体移位(36.7%)、包膜挛缩(33.3%)和患者要求更换尺寸/型号(20.0%)。
  • 总体满意度达89.3%,光滑与毛面TruForm 2亚组分别为90.7%和86.9%。

核心结论

  • Natrelle Inspira TruForm 2假体用于初次隆胸安全,再手术率低且与其它乳房假体一致。

研究设计与样本

  • 回顾性、非干预性研究,在加拿大16个中心回顾病历和患者问卷。
  • 纳入319例22岁及以上、经乳房下皱襞切口行初次隆胸并随访2-4年的女性。

主要发现

  • 30例(9.4%)接受再手术,光滑TruForm 2亚组19例(9.3%),毛面TruForm 2亚组9例(9.1%)。
  • 再手术平均时间1.2年,3年再手术风险率9.9%。
  • 再手术原因:假体移位36.7%、包膜挛缩33.3%、患者要求更换尺寸或型号20.0%。

临床怎么用

  • 临床可参考本研究数据告知患者初次隆胸后再手术风险及常见原因。
  • 选择假体时需考虑患者因素,假体移位和包膜挛缩是再手术常见原因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Reoperation after primary breast augmentation remains an important clinical issue. OBJECTIVE: The authors sought to evaluate incidence and causes of reoperation in patients who underwent primary augmentation. METHODS: This retrospective, noninterventional study conducted at 16 Canadian sites reviewed medical records and patient-completed questionnaires of women who underwent primary breast augmentation with smooth or textured Natrelle Inspira implants containing TruForm 1 or TruForm 2 gel. Patients were aged ≥22 years, received implants via inframammary fold incision, and returned for follow-up at 2 to 4 years. RESULTS: A total of 319 women received Inspira implants (smooth TruForm 2, n = 205; textured TruForm 2, n = 99; smooth or textured TruForm 1, n = 15). At follow-up, 30 women (9.4%) had undergone reoperation, including 19 (9.3%) in the smooth TruForm 2 subgroup and 9 (9.1%) in the textured TruForm 2 subgroup. The mean time to reoperation was 1.2 years; the risk rate for reoperation was 9.9% at 3 years. The most common reasons for reoperation were implant malposition (36.7%), capsular contracture (33.3%), and the patient's request for a change in implant size or style (20.0%). Most women were very or somewhat satisfied with the initial surgery (89.3% overall; 90.7% smooth TruForm 2; 86.9% textured TruForm 2). Thirty-four women (10.7%) reported adverse events, including 20 (9.8%) in the smooth TruForm 2 subgroup and 14 (14.1%) in the textured TruForm 2 subgroup. CONCLUSIONS: This analysis suggests that Natrelle Inspira TruForm 2 implants are safe when used in primary breast augmentation, resulting in low reoperation rates that are consistent with those for other breast implants.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Khanna J, Mosher M, Whidden P, et al. Reoperation Rate After Primary Augmentation With Smooth, Textured, High Fill, Cohesive, Round Breast Implants (RANBI-I Study). Aesthet Surg J. 2019. PMID: 30383228. doi:10.1093/asj/sjy289

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。